rev:  February 3, 2004

HOME (index page)

Return (alphabetical antibody page)


(anti-Human and others as indicated)

RDI Divison of Fitzgerald Industries Intl  offers a wide line of  antibodies. Since no one antibody works best for all applications (neutralization, blotting, ELISA, etc), we offer many different types of antibodies to help solve this problem. Please inquire for other applications or types of antibodies not listed below.

RAT anti-Perlecan (Heparin Sulfate Proteoglycan)

cat# RDI-PERLECabrt           $438.00/100ug

       RDI-PERLECabrt-1        $688.00/200ug

       RDI-PERLECabrt-BT     $562.00/100ug Biotin conj

       RDI-PERLECabrt-BT1   $938.00/200ug Biotin conj

Presentation: Protein G purified antibody in 10mM PBS with 0.2% BSA and 15mM NaN3. (Bulk available without BSA/Azide upon request) concentration 200ug/ml  $750.00/200ug in 0.2ml (no Azide/No BSA, order cat#RDI-PERLECabrt-1XP)

Immunogen: EHS laminin preparation

Isotype: RatIgG2ak

Clone: A7L6

Reactivity: human, mouse, pig and bovine(others not tested)

Uses: -Western blot: 1ug/ml for 2 hours rt (use immobilon membranes)

        -histochemistry (acetone fixed frozen sections, alcohol fixed paraffin, not with routine formalin fixed paraffin approx 10ug/ml for 60 minutes RT

        -Immunohistology (Frozen and Acid-alcohol-fixed, paraffin-embedded 1 ) (Use Ab at 2µg/ml for 30 min at RT)

* Staining of acid-alcohol fixed tissues requires antigen unmasking with 15,000U/ml of bovine testicular hyaluronidase (Sigma) in PBS, pH 7.4 for 30 min at 37C

Positive Ctrl: breast carcinomas, squamouse cell carcinomas

Localization: basement membrane

Background: Perlecan is a major heparan-sulfate proteoglycan (HSPG) within all basement membranes and cell surfaces. Because of its strategic location and ability to store and protect growth factors, perlecan has been strongly implicated in the control of tumor cell growth and metastatic behavior. Perlecan possesses angiogenic and growth-promoting attributes primarily by acting as a coreceptor for basic fibroblast growth factor (FGF-2). Suppression of perlecan causes substantial inhibition of neoplastic growth and neovascularization. Thus, perlecan is a potent inducer of neoplasm growth and angiogenesis in vivo and therapeutic interventions targeting this key modulator of tumor progression may improve neoplastic treatment. This antibody does not cross-react with (laminin, dermatran sulfate proteoglycan) or fibronectin.

Storage: 2-8 deg c


ref: 1. Folkvord et. al., J Histochem Cytochem, 1989; 37:105-113.

2. Couchman et. al., Matrix, 1989; 9:311-321.

3. Horiguchi et. al., J Histochem Cytochem, 1989;37:961-970.

4. Ljubimov et. al., Int J Cancer, 1992; 50:562-566.

5. Guelstein et. al., Int J Cancer, 1993; 53:269-277.

6. Ljubimov et. al., Lab Invest, 1995; 72:461-473.

For Research Use Only

-For Research Use Only

need a secondary antibody?
RDI Divison of Fitzgerald Industries Intl

34 Junction Square Drive

Concord MA 01742-3049


phone (800) 370-2222

      or (978) 371-6446 or (800) 370-2222

fax     (978) 371-2266

Return (alphabetical antibody page)

Ordering terms